EFFECT OF CHANGING PATTERNS OF CARE AND DURATION OF SURVIVAL ON THE COST OF TREATING THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS)

被引:38
作者
SEAGE, GR
LANDERS, S
LAMB, GA
EPSTEIN, AM
机构
[1] BOSTON UNIV,SCH PUBL HLTH,EPIDEMIOL & BIOSTAT SECT,BOSTON,MA 02215
[2] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,BOSTON,MA 02115
[3] HARVARD UNIV,SCH PUBL HLTH,BOSTON,MA 02115
关键词
D O I
10.2105/AJPH.80.7.835
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We performed a two-year cost of illness study of 240 AIDS patients (55 percent of all Massachusetts cases) diagnosed and treated at five hospitals from March 1984 through February 1986. Sociodemographic and clinical data as well as information on medical utilization were obtained from review of inpatient and outpatient hospital records. The yearly inpatient cost per patient decreased by 28 percent from $38,369 in year one to $27,714 in year two. These changes were related to shorter lengths of stay (from 20.6 days to 16.8 days per hospitalization, mean difference of 3.8 days, 95% CI of the difference -.2, 7.8), and less costly hospitalizations (from $12,463 to $9,957, mean difference of $2,506, 95% CI of the difference $135, $4,877). The probability of hospitalization, however, was similar in both years. These patterns of care were still evident after controlling for transmission category, race, site, mortality, insurance, age, gender, number and type of opportunistic diseases and time since diagnosis. Although the cost per patient per year decreased between years one and two, median survival increased by 70 percent (from 10 to 17 months). Hence overall estimated lifetime costs increased by 24 percent.
引用
收藏
页码:835 / 839
页数:5
相关论文
共 28 条
  • [1] ANDERSON S, 1980, STATISTICAL METHODS
  • [2] ANDRULIS DP, 1987, JAMA-J AM MED ASSOC, V258, P1343
  • [3] ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS)
    BARRESINOUSSI, F
    CHERMANN, JC
    REY, F
    NUGEYRE, MT
    CHAMARET, S
    GRUEST, J
    DAUGUET, C
    AXLERBLIN, C
    VEZINETBRUN, F
    ROUZIOUX, C
    ROZENBAUM, W
    MONTAGNIER, L
    [J]. SCIENCE, 1983, 220 (4599) : 868 - 871
  • [4] SURVIVAL EXPERIENCE AMONG PATIENTS WITH AIDS RECEIVING ZIDOVUDINE - FOLLOW-UP OF PATIENTS IN A COMPASSIONATE PLEA PROGRAM
    CREAGHKIRK, T
    DOI, P
    ANDREWS, E
    NUSINOFFLEHRMAN, S
    TILSON, H
    HOTH, D
    BARRY, DW
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (20): : 3009 - 3015
  • [5] *CTR DIS CONTR, 1989, AIDS WEEKL SURV REP
  • [6] CURRAN JW, 1988, 4 INT C ACQ IMM SYND, V1, P106
  • [7] DRUCKER E, 1987, 3 INT C AIDS
  • [8] FANNING MM, 1987, 3 INT C AIDS
  • [9] THE EFFICACY OF AZIDOTHYMIDINE (AZT) IN THE TREATMENT OF PATIENTS WITH AIDS AND AIDS-RELATED COMPLEX - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    FISCHL, MA
    RICHMAN, DD
    GRIECO, MH
    GOTTLIEB, MS
    VOLBERDING, PA
    LASKIN, OL
    LEEDOM, JM
    GROOPMAN, JE
    MILDVAN, D
    SCHOOLEY, RT
    JACKSON, GG
    DURACK, DT
    KING, D
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (04) : 185 - 191
  • [10] GALLO RC, 1984, SCIENCE, V225, P840